Skip to main content

Table 2 Results of PlGF and fetal flow tests, by outcome and diagnosis (N=89)

From: Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study

 

Normal PlGF

Low PlGF

Very Low PlGF

Fetal flow

Normal

Abnormal

Normal

Abnormal

Normal

Abnormal

n

22

0

23

3

24

17

Percent of N

(24.7)

0.0

(25.8)

(3.4)

(27.0)

(19.1)

Preterm

5 (22.7)

 

14 (60.9)

3 (100.0)

22 (91.7)

17 (100.0)

IUGR

0 (0.0)

 

3 (13.0)

3 (100.0)

9 (37.5)

7 (41.2)

CHT

8 (36.4)

 

11 (47.8)

0 (0.0)

2 (8.3)

3 (17.6)

GHT

10 (45.5)

 

3 (13.0)

1 (33.3)

2 (8.3)

1 (5.9)

HELLP

0 (0.0)

 

2 (8.7)

0 (0.0)

6 (25.0)

4 (23.5)

PE

1 (4.5)

 

2 (8.7)

1 (33.3)

10 (41.7)

5 (29.4)

SIPE

3 (13.6)

 

5 (21.7)

1 (33.3)

4 (16.7)

4 (23.5)

  1. Breakout of N=89 subjects by three placental growth factor test result groups (normal PlGF≥100, low 12<PlGF<100, and very low PlGF≤12) and two fetal flow groups (abnormal, normal). The breakout by outcomes (preterm birth, IUGR infant) and diagnosis shows the number and percent (relative to n) for each category. Intrauterine growth restriction (IUGR); chronic hypertension (CHT); gestational hypertension (GHT); hemolysis, elevated liver enzymes and low platelet count syndrome (HELLP); preeclampsia (PE); superimposed preeclampsia (SIPE).
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us